Novel Coronavirus (SARS-CoV-2/COVID-19)
The New England Journal of Medicine last week released a study showing that the use of dexamethasone resulted in a lower, 28-day mortality rate among patients receiving invasive ventilation or oxygen.
A COVID-19 trial vaccine developed by the University of Oxford and AstraZeneca produced neutralizing antibody responses in patients with SARS-CoV-2, according to a study published July 20 in The Lancet.
When the COVID-19 pandemic emerged, hospitals had to stop all but the most urgent non-COVID care. The result was a dramatic slowdown in volume of patients and in revenue, while expenses remained high. The result has been an unprecedented impact and an uncertain future about the ability of hospitals鈥
In 2016, His Holiness the Dalai Lama and former Archbishop Desmond Tutu spent one week together in deep discussion about joy. How to obtain it and hold on to it in a changing and often chaotic world.
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response July 21 at 12 p.m. ET will host a COVID-19 webinar on 鈥淐ritical Care: Lifesaving Treatment and Clinical Operations.鈥
The Food and Drug Administration at 8 p.m. will close its COVID-19 hotline for questions related to COVID-19 diagnostic tests and device shortages, including personal protective equipment and respirators.
The Centers for Disease Control and Prevention is developing guidance that will no longer recommend a second negative test within 24 hours before COVID-19 patients emerge from isolation, according to news reports from a press call with Brett Giroir, M.D., assistant secretary for health at the鈥
The Federal Reserve Board modified the Main Street Lending Program to provide a new borrowing option for nonprofit organizations including hospitals, a move advocated for by the AHA.
The AHA, American Medical Association, and American Nurses Association urged Senate leaders to include in the next COVID-19 relief bill provisions to strengthen the federal response for racial and ethnic minority and marginalized communities, which are disproportionately affected by the pandemic.
In situations where supplies are limited, the National Institutes of Health鈥檚 COVID-19 Treatment Guidelines Panel recommended prioritizing remdesivir for use in hospitalized patients with COVID-19 who require supplemental oxygen but are not mechanically ventilated or on extracorporeal membrane鈥